|
|
Volumn 5, Issue 3, 2008, Pages 156-
|
|
Metformin: A multitasking medication
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTIDIABETIC AGENT;
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
BIGUANIDE DERIVATIVE;
BUFORMIN;
INSULIN;
METFORMIN;
PHENFORMIN;
ANTINEOPLASTIC ACTIVITY;
CARDIOVASCULAR RISK;
DRUG ACCUMULATION;
DRUG CHOICE;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG MONITORING;
DRUG SAFETY;
DRUG TOLERABILITY;
EDITORIAL;
EVIDENCE BASED MEDICINE;
GENETIC VARIABILITY;
GLYCEMIC CONTROL;
HUMAN;
HYPERGLYCEMIA;
INSULIN BLOOD LEVEL;
INSULIN RESISTANCE;
LACTIC ACIDOSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONALCOHOLIC FATTY LIVER;
OVARY POLYCYSTIC DISEASE;
PHARMACOGENETICS;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
WEIGHT GAIN;
ADMINISTRATION, ORAL;
BLOOD GLUCOSE;
CARDIOVASCULAR AGENTS;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
METFORMIN;
TREATMENT OUTCOME;
|
|
EID: 51749122407
PISSN: 14791641
EISSN: None
Source Type: Journal
DOI: 10.3132/dvdr.2008.026 Document Type: Editorial |
|
Times cited : (16)
|
|
References (0)
|
